SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-031257
Filing Date
2014-08-07
Accepted
2014-08-07 16:15:43
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP 10-Q 6-30-2014 form10q.htm 10-Q 720324
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9043
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9148
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 7866
  Complete submission text file 0001140361-14-031257.txt   5418353

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rptp-20140630.xml EX-101.INS 751555
6 XBRL TAXONOMY EXTENSION SCHEMA rptp-20140630.xsd EX-101.SCH 41602
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20140630_cal.xml EX-101.CAL 55512
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20140630_def.xml EX-101.DEF 149836
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20140630_lab.xml EX-101.LAB 545583
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20140630_pre.xml EX-101.PRE 295542
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 141024110
SIC: 2834 Pharmaceutical Preparations